Safety of intravitreal dexamethasone implant (ozurdex): the safodex study. incidence and risk factors of ocular hypertension

Malcles, Ariane; Dot, Corinne; Voirin, Nicolas; Vie, Anne-Laure; Agard, Émilie; Bellocq, David; Denis, Philippe; Kodjikian, Laurent

doi:10.1097/IAE.0000000000001369

Scientific article

Open access

English

Safety of intravitreal dexamethasone implant (ozurdex): the safodex study. incidence and risk factors of ocular hypertension

ContributorsMalcles, Ariane

; Dot, Corinne; Voirin, Nicolas; Vie, Anne-Laure; Agard, Émilie; Bellocq, David; Denis, Philippe; Kodjikian, Laurent

Published inRetina, vol. 37, no. 7, p. 1352-1359

Publication date2017

Abstract

To analyze the incidence, risk factors, and time course of intraocular pressure elevation after intravitreal dexamethasone implant (Ozurdex).

Affiliation

Faculté de médecine / Section de médecine clinique / Département des neurosciences cliniques

Research group

Ophtalmologie expérimentale (925)

Citation (ISO format)

MALCLES, Ariane et al. Safety of intravitreal dexamethasone implant (ozurdex): the safodex study. incidence and risk factors of ocular hypertension. In: Retina, 2017, vol. 37, n° 7, p. 1352–1359. doi: 10.1097/IAE.0000000000001369

Article (Published version)

Identifiers

PID : unige:92783
DOI : 10.1097/IAE.0000000000001369
PMID : 27768641

ISSN of the journal1539-2864

529views

554downloads

Creation11/29/2016 2:39:00 PM

First validation11/29/2016 2:39:00 PM

Update time03/15/2023 1:29:27 AM

Status update03/15/2023 1:29:27 AM

Last indexation05/02/2024 6:15:07 PM

Archive ouverte UNIGE

Safety of intravitreal dexamethasone implant (ozurdex): the safodex study. incidence and risk factors of ocular hypertension

To analyze the incidence, risk factors, and time course of intraocular pressure elevation after intravitreal dexamethasone implant (Ozurdex).

Technical informations